BMO: Celgene Still A Buy On This 'Important Future Driver'
May 28, 2015 at 10:14 AM EDT
In a report published Thursday, BMO Capital analyst Jim Birchenough maintained his Outperform rating on Celgene Corporation (NASDAQ: ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.